LIST OF TABLES
TABLE 1. GLOBAL JAPAN GENERIC DRUGS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 2. JAPAN GENERIC DRUGS MARKET FOR GENERIC PRESCRIPTION MEDICINES, BY REGION, 2022-2032 ($MILLION)
TABLE 3. JAPAN GENERIC DRUGS MARKET FOR SUPER GENERICS, BY REGION, 2022-2032 ($MILLION)
TABLE 4. JAPAN GENERIC DRUGS MARKET FOR BIOSIMILARS, BY REGION, 2022-2032 ($MILLION)
TABLE 5. GLOBAL JAPAN GENERIC DRUGS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 6. JAPAN GENERIC DRUGS MARKET FOR CARDIOVASCULAR PRODUCTS, BY REGION, 2022-2032 ($MILLION)
TABLE 7. JAPAN GENERIC DRUGS MARKET FOR ANTI-INFECTIVE DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 8. JAPAN GENERIC DRUGS MARKET FOR ANTI-ARTHRITIS DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 9. JAPAN GENERIC DRUGS MARKET FOR CENTRAL NERVOUS SYSTEM DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. JAPAN GENERIC DRUGS MARKET FOR ANTI-CANCER DRUG, BY REGION, 2022-2032 ($MILLION)
TABLE 11. JAPAN GENERIC DRUGS MARKET FOR RESPIRATORY PRODUCTS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. JAPAN GENERIC DRUGS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. GLOBAL JAPAN GENERIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 14. JAPAN GENERIC DRUGS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. JAPAN GENERIC DRUGS MARKET FOR PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 16. JAPAN GENERIC DRUGS MARKET FOR PRIVATE CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 17. JAPAN GENERIC DRUGS MARKET FOR DRUG STORES, BY REGION, 2022-2032 ($MILLION)
TABLE 18. JAPAN GENERIC DRUGS MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 19. JAPAN GENERIC DRUGS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 20. JAPAN GENERIC DRUGS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA JAPAN GENERIC DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 25. U.S. JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 26. U.S. JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. U.S. JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 28. CANADA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 29. CANADA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. CANADA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 31. MEXICO JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 32. MEXICO JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. MEXICO JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 34. EUROPE JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 35. EUROPE JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. EUROPE JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 37. EUROPE JAPAN GENERIC DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 38. FRANCE JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 39. FRANCE JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. FRANCE JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 41. GERMANY JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 42. GERMANY JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. GERMANY JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 44. ITALY JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 45. ITALY JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. ITALY JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 47. SPAIN JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 48. SPAIN JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. SPAIN JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 50. UK JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 51. UK JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. UK JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 53. RUSSIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 54. RUSSIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. RUSSIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 56. REST OF EUROPE JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 57. REST OF EUROPE JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. REST OF EUROPE JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 59. ASIA-PACIFIC JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 60. ASIA-PACIFIC JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. ASIA-PACIFIC JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 62. ASIA-PACIFIC JAPAN GENERIC DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 63. CHINA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 64. CHINA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. CHINA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 66. JAPAN JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 67. JAPAN JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. JAPAN JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 69. INDIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 70. INDIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. INDIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 72. SOUTH KOREA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 73. SOUTH KOREA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. SOUTH KOREA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 75. AUSTRALIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 76. AUSTRALIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. AUSTRALIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 78. THAILAND JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 79. THAILAND JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. THAILAND JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 81. MALAYSIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 82. MALAYSIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. MALAYSIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 84. INDONESIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 85. INDONESIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. INDONESIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 87. REST OF ASIA PACIFIC JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF ASIA PACIFIC JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. REST OF ASIA PACIFIC JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 90. LAMEA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 91. LAMEA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 92. LAMEA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 93. LAMEA JAPAN GENERIC DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 94. BRAZIL JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 95. BRAZIL JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 96. BRAZIL JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 97. SOUTH AFRICA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 98. SOUTH AFRICA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. SOUTH AFRICA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 100. SAUDI ARABIA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 101. SAUDI ARABIA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 102. SAUDI ARABIA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 103. UAE JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 104. UAE JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 105. UAE JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 106. ARGENTINA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 107. ARGENTINA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. ARGENTINA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 109. REST OF LAMEA JAPAN GENERIC DRUGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 110. REST OF LAMEA JAPAN GENERIC DRUGS, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA JAPAN GENERIC DRUGS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 112. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 113. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 114. TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING SEGMENTS
TABLE 115. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 116. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. NICHI-IKO PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 118. NICHI-IKO PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 119. NICHI-IKO PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
TABLE 120. NICHI-IKO PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 121. NICHI-IKO PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. SAWAI PHARMACEUTICALS CO., LTD.: KEY EXECUTIVES
TABLE 123. SAWAI PHARMACEUTICALS CO., LTD.: COMPANY SNAPSHOT
TABLE 124. SAWAI PHARMACEUTICALS CO., LTD.: OPERATING SEGMENTS
TABLE 125. SAWAI PHARMACEUTICALS CO., LTD.: PRODUCT PORTFOLIO
TABLE 126. SAWAI PHARMACEUTICALS CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. NIPRO MEDICAL CORPORATION: KEY EXECUTIVES
TABLE 128. NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 129. NIPRO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 130. NIPRO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 131. NIPRO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. MEIJI SEIKA PHARMA CO., LTD.: KEY EXECUTIVES
TABLE 133. MEIJI SEIKA PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 134. MEIJI SEIKA PHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 135. MEIJI SEIKA PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 136. MEIJI SEIKA PHARMA CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 137. TOWA PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 138. TOWA PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 139. TOWA PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
TABLE 140. TOWA PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 141. TOWA PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 142. HIKARI PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 143. HIKARI PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 144. HIKARI PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
TABLE 145. HIKARI PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 146. HIKARI PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 147. FUJI PHARMA CO., LTD.: KEY EXECUTIVES
TABLE 148. FUJI PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 149. FUJI PHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 150. FUJI PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 151. FUJI PHARMA CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 152. MYLAN N.V.: KEY EXECUTIVES
TABLE 153. MYLAN N.V.: COMPANY SNAPSHOT
TABLE 154. MYLAN N.V.: OPERATING SEGMENTS
TABLE 155. MYLAN N.V.: PRODUCT PORTFOLIO
TABLE 156. MYLAN N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 157. GLAXOSMITHKLINE PLC.: KEY EXECUTIVES
TABLE 158. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
TABLE 159. GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
TABLE 160. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 161. GLAXOSMITHKLINE PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL JAPAN GENERIC DRUGS MARKET SEGMENTATION
FIGURE 2. GLOBAL JAPAN GENERIC DRUGS MARKET
FIGURE 3. SEGMENTATION JAPAN GENERIC DRUGS MARKET
FIGURE 4. TOP INVESTMENT POCKET IN JAPAN GENERIC DRUGS MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALJAPAN GENERIC DRUGS MARKET
FIGURE 11. JAPAN GENERIC DRUGS MARKET SEGMENTATION, BY PRODUCT TYPE
FIGURE 12. JAPAN GENERIC DRUGS MARKET FOR GENERIC PRESCRIPTION MEDICINES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. JAPAN GENERIC DRUGS MARKET FOR SUPER GENERICS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. JAPAN GENERIC DRUGS MARKET FOR BIOSIMILARS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 15. JAPAN GENERIC DRUGS MARKET SEGMENTATION, BY APPLICATION
FIGURE 16. JAPAN GENERIC DRUGS MARKET FOR CARDIOVASCULAR PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 17. JAPAN GENERIC DRUGS MARKET FOR ANTI-INFECTIVE DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 18. JAPAN GENERIC DRUGS MARKET FOR ANTI-ARTHRITIS DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 19. JAPAN GENERIC DRUGS MARKET FOR CENTRAL NERVOUS SYSTEM DRUGS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 20. JAPAN GENERIC DRUGS MARKET FOR ANTI-CANCER DRUG, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 21. JAPAN GENERIC DRUGS MARKET FOR RESPIRATORY PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 22. JAPAN GENERIC DRUGS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 23. JAPAN GENERIC DRUGS MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
FIGURE 24. JAPAN GENERIC DRUGS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 25. JAPAN GENERIC DRUGS MARKET FOR PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 26. JAPAN GENERIC DRUGS MARKET FOR PRIVATE CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 27. JAPAN GENERIC DRUGS MARKET FOR DRUG STORES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 28. JAPAN GENERIC DRUGS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 29. JAPAN GENERIC DRUGS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 34. COMPETITIVE DASHBOARD
FIGURE 35. COMPETITIVE HEATMAP: JAPAN GENERIC DRUGS MARKET
FIGURE 36. TOP PLAYER POSITIONING,2022
FIGURE 37. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 38. TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 39. TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 40. NICHI-IKO PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 41. NICHI-IKO PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 42. NICHI-IKO PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 43. SAWAI PHARMACEUTICALS CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 44. SAWAI PHARMACEUTICALS CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 45. SAWAI PHARMACEUTICALS CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 46. NIPRO MEDICAL CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 47. NIPRO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 48. NIPRO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 49. MEIJI SEIKA PHARMA CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 50. MEIJI SEIKA PHARMA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 51. MEIJI SEIKA PHARMA CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 52. TOWA PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 53. TOWA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 54. TOWA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 55. HIKARI PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. HIKARI PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 57. HIKARI PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 58. FUJI PHARMA CO., LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 59. FUJI PHARMA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 60. FUJI PHARMA CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 61. MYLAN N.V.: NET SALES, 2020-2022 ($MILLION)
FIGURE 62. MYLAN N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 63. MYLAN N.V.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 64. GLAXOSMITHKLINE PLC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 65. GLAXOSMITHKLINE PLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 66. GLAXOSMITHKLINE PLC.: REVENUE SHARE, BY REGION, 2032 (%)